Thursday, January 21, 2021

It’s your money. If you want to blow it up, fine: Adar’s father on vaccine bet

- Advertisement -

adar poonawalaNew Delhi, Nov 13 (IANS) Adar Poonawalla, CEO and Owner of Serum Institute of India (SII) is putting $250 million of his familys fortune into a bid to ramp up manufacturing capacity to 1 billion doses through 2021.

“I decided to go all out,” said the 39-year-old said. Among the initial skeptics were his father, Cyrus, the company’s founder.

“He said: ‘Look, it’s your money. If you want to blow it up, fine?’,” Adar said in an interview to The Washington Post.

One prominent vaccine candidate requiring ultra-cold storage is “a joke” that will not work for the developing world. Anyone who declares how long a vaccine will confer immunity is talking “nonsense”.

The world’s entire population will not be immunized until 2024, he says, contrary to rosier predictions.

READ ALSO:  More than Rs 1cr used to manage delhi protests, reveals chargesheet

Poonawalla is equally frank about the gamble his company, Serum Institute of India, is making in the pandemic.

Gavi (the vaccine alliance) and the Gates Foundation “want to assure vaccine supply at an affordable price,” said Poonawalla, Serum’s chief executive. His aim, meanwhile, is to cover some of his costs. “At least my risk is taken away so I can sleep at night,” he said, the report said.

The company has diverted capacity from existing vaccines and started work on a new production facility to be completed next year at its headquarters in Pune.

Poonawalla said the company has pledged to keep half of the vaccines it makes for use within India. It has already begun manufacturing the AstraZeneca vaccine, he said. About 20 million doses have been made, and he expects to have 10 times that amount ready in the next four months, the report said.

READ ALSO:  Situation along China border tense, nation but can count on us: Army Chief
READ ALSO:  India, China Defence Ministers agree to resolve border tensions

He is optimistic that in 2021, a new coronavirus vaccine will be licensed for public use every couple of months. “That’s the good news,” Poonawalla said.

The less-good news is that it remains unclear which vaccine, if any, will offer long-term protection from the virus. “Nobody wants a vaccine that is only going to protect you for a few months,” he said, the report said.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

Related News


Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India

Trump who? Joe Biden and Kamala Harris Inauguration Day highlights

By Nikhila Natarajan (IANS) In the span of about about 120 minutes, between the hours of 10.30 a.m. and 12.30 p.m. on Wednesday, the...

Rahane’s success as Test captain puts pressure on Kohli

By Khurram Habib (IANS) Ajinkya Rahane's ability to lead a weak Indian team, with many second string or young players to a Test series...

Amid protests and fracas, Mumbai Police book ‘Tandav’ team

Mumbai, Jan 20 (IANS): As a controversy and protests raged across India, the Mumbai Police on Wednesday lodged a first information report (FIR) against the...

57 players released by 8 IPL franchises ahead of auction

New Delhi, Jan 20 (IANS): Fifty-seven players have been released by eight Indian Premier League (IPL) franchises ahead of the 2021 auction, to be held...